Mahajan, U. M., Oehrle, B., Sirtl, S., Alnatsha, A., Goni, E., Regel, I., . . . Mayerle, J. (2022). Independent validation and assay standardization of improved metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Gastroenterology, 163(5), . https://doi.org/10.1053/j.gastro.2022.07.047
Chicago-Zitierstil (17. Ausg.)Mahajan, Ujwal Mukund, et al. "Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma from Chronic Pancreatitis." Gastroenterology 163, no. 5 (2022). https://doi.org/10.1053/j.gastro.2022.07.047.
MLA-Zitierstil (9. Ausg.)Mahajan, Ujwal Mukund, et al. "Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma from Chronic Pancreatitis." Gastroenterology, vol. 163, no. 5, 2022, https://doi.org/10.1053/j.gastro.2022.07.047.